Identification of multiple subclasses of plasma low density lipoproteins in normal humans

Author(s): Krauss RM, Burke DJ

Abstract

Density gradient ultracentrifugation of low density lipoproteins (LDL) from 12 normal subjects showed multiple, distinct isopycnic bands. Densitometric scanning of the gradient tubes revealed that each band could be assigned to one of four density intervals and that the boundaries of these intervals were consistent among all the subjects. Analytic ultracentrifuge flotation (S(f)(0)) rates were assigned to the four density intervals, and there was a strong correlation between peak S(f)(0) rate and peak isopycnic banding position (R(f)) of the LDL in the 12 subjects. The S(f)(0) value corresponding to the boundary between the two most buoyant LDL density subgroups was 7.5. This value is close to that previously demonstrated to define two LDL subdivisions (S(f)(0) 0-7 and S(f)(0) 7-12) that were discriminated by differing concentrations in men and women, and differing statistical relationships with levels of HDL and VLDL in a normal population. Further delineation of distinct subspecies of LDL was afforded by electrophoresis in 2-16% gradient polyacrylamide gels. Densitometric scans of protein-stained gels revealed multiple peaks, and particle diameters were assigned to these peaks using calibration markers. Particles of diameter >/= 280 A included both IDL and Lp(a), the latter defined by pre-beta mobility on agarose electrophoresis and density > 1.050 g/ml. LDL particles with diameters 220-272 A could be grouped into seven size intervals defined by modes in the distribution of gradient gel electrophoretic peaks in LDL from a group of 68 healthy men and women. Particle diameters of the major peaks in each of seven density subfractions decreased with increasing density of the fractions. However, particles within each of the size groups were distributed across a range of densities. Use of a lipid-staining procedure allowed identification of electrophoretic bands in whole plasma which corresponded to those seen in isolated LDL, eliminating the possibility that ultracentrifugation was responsible for formation of the subspecies detected by the gradient gel procedure. The application of density gradient ultracentrifugation and gradient gel electrophoresis provides a means of characterizing LDL from normal humans in terms of multiple distinct subpopulations which may also prove to have differing metabolic and pathologic properties.-Krauss, R. M., and D. J. Burke. Identification of multiple subclasses of plasma low density lipoproteins in normal humans.

Similar Articles

LDL cholesterol: the lower the better

Author(s): Martin SS, Blumenthal RS, Miller M

High density lipoproteins and atherosclerosis: emerging aspects

Author(s): Sala F, Catapano AL, Norata GD

High-density lipoprotein function, dysfunction, and reverse cholesterol transport

Author(s): Fisher EA, Feig JE, Hewing B, Hazen SL, Smith JD

Targeting Innate Immunity for CV Benefit

Author(s): Moore KJ, Freeman MW

Blood serum atherogenicity associated with coronary atherosclerosis

Author(s): Orekhov AN, Tertov VV, Pokrovsky SN, Adamova IYu, Martsenyuk ON, et al.

Characteristics of low density lipoprotein isolated from circulating immune complexes

Author(s): Tertov VV, Sobenin IA, Orekhov AN, Jaakkola O, Solakivi T, et al.

Human plasma trans-sialidase causes atherogenic modification of low density lipoprotein

Author(s): Tertov VV, Kaplun VV, Sobenin IA, Boytsova EY, Bovin NV, et al.

Presence of a modified low density lipoprotein in humans

Author(s): Avogaro P, Bon GB, Cazzolato G

Autoantibodies against modified low density lipoprotein

Author(s): Orekhov AN, Tertov VV, Kabakov AE, Adamova IYu, Pokrovsky SN, et al.

Low density lipoprotein-containing circulating immune complexes and coronary atherosclerosis

Author(s): Tertov VV, Orekhov AN, Kacharava AG, Sobenin IA, Perova NV, et al.

Lipoprotein immune complexes as markers of atherosclerosis

Author(s): Orekhov AN, Kalenich OS, Tertov VV, Novikov ID

Diagnostic value of immune cholesterol as a marker for atherosclerosis

Author(s): Orekhov AN, Kalenich OS, Tertov VV, Perova NV, Novikov IyD, et al.

Diagnostic and prognostic value of low density lipoprotein-containing circulating immune complexes in atherosclerosis

Author(s): Sobenin IA, Karagodin VP, Melnichenko AC, Bobryshev YV, Orekhov AN

Pluronic block copolymers inhibit low density lipoprotein self-association

Author(s): Melnichenko AA, Aksenov DV, Myasoedova VA, Panasenko OM, Yaroslavov AA, et al.

Three-dimensional cytoarchitecture of normal and atherosclerotic intima of human aorta

Author(s): Rekhter MD, Andreeva ER, Mironov AA, Orekhov AN

Primary cultures of enzyme-isolated cells from normal and atherosclerotic human aorta

Author(s): Orekhov AN, Andreeva ER, Krushinsky AV, Smirnov VN

Lipids in cells of atherosclerotic and uninvolved human aorta

Author(s): Orekhov AN, Tertov VV, Novikov ID, Krushinsky AV, Andreeva ER, et al.

Adult human aortic cells in primary culture: heterogeneity in shape

Author(s): Orekhov AN, Krushinsky AV, Andreeva ER, Repin VS, Smirnov VN

Cell proliferation in normal and atherosclerotic human aorta

Author(s): Orekhov AN, Kosykh VA, Repin VS, Smirnov VN

Primary culture of human aortic intima cells as a model for testing anti-atherosclerotic drugs

Author(s): Orekhov AN, Tertov VV, Kudryashov SA, Khashimov KhA, Smirnov VN

Atherogenicity of blood serum from patients with coronary heart disease

Author(s): Chazov EI, Tertov VV, Orekhov AN, Lyakishev AA, Perova NV, et al.

Antiatherosclerotic effects of calcium antagonists

Author(s): Orekhov AN, Baldenkov GN, Tertov VV, Ruda MYa, Khashimov KA, et al.

Effects of garlic on atherosclerosis

Author(s): Orekhov AN, Grünwald J

Anti-atherosclerotic therapy based on botanicals

Author(s): Orekhov AN, Sobenin IA, Korneev NV, Kirichenko TV, Myasoedova VA, et al.

The antiatherosclerotic effect of Allium sativum

Author(s): Koscielny J, Klüssendorf D, Latza R, Schmitt R, Radtke H, et al.

Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II) Am J Cardiol 75: 455-459

Author(s): Crouse JR 3rd, Byington RP, Bond MG, Espeland MA, Craven TE, et al.

Kuopio Atherosclerosis Prevention Study (KAPS)

Author(s): Salonen R, Nyyssönen K, Porkkala E, Rummukainen J, Belder R, et al.

Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events

Author(s): Pitt B, Byington RP, Furberg CD, Hunninghake DB, Mancini GB, et al.

Beneficial effects of colestipol-niacin therapy on the common carotid artery

Author(s): Blankenhorn DH, Selzer RH, Crawford DW, Barth JD, Liu CR, et al.

Coronary angiographic changes with lovastatin therapy

Author(s): Blankenhorn DH, Azen SP, Kramsch DM, Mack WJ, Cashin-Hemphill L, et al.

Carotid plaque morphologic characteristics

Author(s): Aidinian G, Weiswasser JM, Arora S, Abularrage CJ, Singh N, et al.

Thematic review series: The immune system and atherogenesis

Author(s): Daugherty A, Webb NR, Rateri DL, King VL

Evidence-based assessment of the impact of the WHI on women's health

Author(s): Burger HG, MacLennan AH, Huang KE, Castelo-Branco C